Latest The FASEB Journal Stories
New research in the FASEB Journal suggests that increasing the level of the P450 protein causes the creation of molecules called EETs, which lower blood pressure.
New hypothesis in the FASEB Journal suggests balance between NF-kB and p53 signaling is a promising target for new drugs.
Here's good news for anyone trying to lose weight or has osteoporosis: Scientists from Maine are on the trail of a weight loss drug that may revolutionize how we treat these two conditions.
At a time when great jobs are hard to find, here's good news for the under-qualified: A new article appearing in the FASEB Journal (http://www.fasebj.org) shows that being a highly cited researcher may not be a primary qualification for taking on leading management positions at research institutions.
New research in the FASEB Journal shows that a peptide derived from bee venom can deliver liposomes bearing drugs or diagnostic dyes to specific cells or tissues.
New research in the FASEB Journal suggests that the polyphenols in virgin olive oil modify the expression of atherosclerosis-related genes, leading to health benefits.
New research in the FASEB Journal shows that defensin-1, a protein added to honey by bees, possesses potent antibacterial properties and could be used again drug-resistant bacteria.
New report in the FASEB Journal suggests that disrupting a particular cellular signaling pathway could stop or slow the initiation, promotion, and progression of prostate cancer.
New research published in the FASEB Journal suggests that Lactobacillus reuteri immediately affects nerves in the gut, explaining how probiotics work.
In the future, summer sun may never be viewed the same way again: New research in the FASEB Journal will help doctors predict your likelihood to develop skin cancer, and promises next-generation sunscreens.